Barclays analyst Emily Field maintained a Hold rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of CHF290.00.

Deutsche Bank analyst Emmanuel Papadakis maintained a Sell rating on Roche Holding AG (RHHVF – Research Report) today and set a price target ...

We recently compiled a list of the Morgan Stanley’s 15 Best European AI Stocks. In this article, we are going to take a look ...

Roche Holding AG said profit will probably outpace sales growth this year as the Swiss drugmaker works to keep research costs in check and looks for deals to build its pipeline of experimental ...

The company expects sales and core earnings to keep growing this year after beating analysts’ expectations for 2024, and the ...

Roche said on Thursday it is targeting a continued increase in adjusted earnings per share (EPS) at a high single-digit ...

Q4 2024 Management View CEO Thomas Schinecker emphasized that 2024 was an "excellent year," with overall group sales growing ...

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products ...

Roche Holding, a Swiss multinational pharmaceutical and diagnostic giant, acquired the business in 2008 for $3.4 billion and has expanded its reach. Ventana had gone public 12 years earlier ...

Roche Holding is scheduled to report results for 2024 on Thursday. Here is what to know. SALES FORECAST: The Swiss pharma giant's sales for last year are forecast at 60.41 billion Swiss francs ($ ...